- Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
- Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
- Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
- Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
- Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
- Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
- Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
- Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
- Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
More ▼
Key statistics
On Monday, Helius Medical Technologies Inc (HSDT:NAQ) closed at 0.721, 10.92% above the 52 week low of 0.65 set on Jul 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.70 |
---|---|
High | 0.758 |
Low | 0.6602 |
Bid | -- |
Offer | -- |
Previous close | 0.721 |
Average volume | 145.10k |
---|---|
Shares outstanding | 2.53m |
Free float | 2.51m |
P/E (TTM) | -- |
Market cap | 1.82m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 29 2024 21:00 BST.
More ▼